Antiphospholipid syndrome and retinal vein occlusion in adults

Eastern Mediterranean Health Journal

Volumn 10, Issue 4-5, 2004, Pages 627-632

  Maaroufi, R M ^a,c   Hamdi, R ^b   Jmili, N ^c   Ghorbal, M ^b   Hamida, F Bel Hadj ^b   Mahjoub, T ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; MALE; PREVALENCE; RETINA ARTERY OCCLUSION; RETINA ISCHEMIA; RETINA VEIN OCCLUSION; VISUAL SYSTEM EXAMINATION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LASER COAGULATION; MALE; MASS SCREENING; MIDDLE AGED; OPHTHALMOSCOPY; PREVALENCE; QUESTIONNAIRES; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; TUNISIA;

EID: 28444448707     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. De Groot PG, Oosting JD, Derksen RH. Antiphospholipid antibodies: specificity and pathophysiology. Balliere's clinical haematology, 1993, 6:691-709.
2. Exner T, Triplett DA. Lupus anticoagulants: characteristics, methods of laboratory detection and some clinical associations. In: Harris EN et al., eds. Phospholipid binding antibodies. Boca Raton, Florida, CRC Press, 1991:141-58.
3. Loizou S et al. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clinical and experimental immunology, 1985, 62:738-45.
4. Harris EN et al. Clinical and serological features of the antiphospholipid syndrome (APS). British journal of rheumatology, 1987, 26:19.
5. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. Journal of rheumatology, 1989, 16:482-8.
6. Italian registry of antiphospholipid antibodies (IR-APA). Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): first report from the Italian registry. Haematologica, 1993, 78:313-8.
7. Khamashta MA. Management of thrombosis in the antiphospholipid syndrome. Lupus, 1996, 5(5):463-6.
8. Abu El-Asrar AM et al. Hypercoagulable states in patients with retinal vein occlusion. Documenta ophthalmologica, 1998, 95(2):133-43.
9. Cobo-Soriano R et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. American journal of ophthalmology, 1999, 128(6):725-32.
10. Coniglio M et al. Antiphospholipid antibodies are not an uncommon feature in retinal venous occlusions. Thrombosis research, 1996, 83(2):183-8.
11. Demirci FY et al. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS. International ophthalmology, 1998, 22(6):323-9.
12. Cobo Soriano R et al. Trombosis retiniana en pacientes jóvenes. Aspectos inmunológicos y clínicos. [Retinal thrombosis in young patients. Immunological and clinical aspects.] Archivos de la Sociedad Española de Oftalmología, 2001, 76(11):641.
13. Ridker PM et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. New England journal of medicine, 1995, 332:912-7.
14. Lellouche F et al. Influence of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood, 1991, 78:2894-9.
15. Karmochkine M et al. The effect of sera with antiphospholipid antibodies on endothelial cell procoagulant activity is dependent upon the charge of the phospholipids against which they are directed. Thrombosis research, 1994, 74:435-40.
16. Cariou R et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells. Inhibition of thrombomodulin-dependent protein C activation. Thrombosis and haemostasis, 1988, 60:54-8.
17. Smirnov MD et al. On the role of phosphatidylethanolamine in the inhibition of protein C activity by antiphospholipid antibodies. Journal of clinical investigation, 1995, 95:309-18.
18. Glacet-Bernard A et al. Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Archives of ophthalmology, 1994, 112(6):790-5.
19. Wiechens B et al. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. American journal of ophthalmology, 1997, 123(6): 848-50.
20. Ermakova NA et al. Rol' antifosfolipidnykh antitel v okkliuzii sosudov setchatki pri razlichnykh sosudistykh zabolevaniiakh glaza. [Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases.] Vestnik oftalmologii, 2002, 118(2):29-32.
21. Carbone J et al. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases. Journal of rheumatology, 2001, 28(11):2437-41.
22. Dunn JP et al. Antiphospholipid antibodies and retinal vascular disease. Lupus, 1996, 5(4):313-22.